The $166 bln Wegovy maker has effectively shed all its share-price gains from a pioneering obesity drug. The key problem: ...
This Research Topic focuses on using artificial intelligence (AI) to combine and analyze diverse biomedical data types to improve the performance and ...
Cardiometabolic diseases - including type 2 diabetes, obesity, hypertension, and dyslipidaemia - remain major contributors to global morbidity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results